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Table 1
Variables
GRACE
<108 points
GRACE
108-140
points
GRACE
>140 points p
Age, years 48.338.77z 55.528.87z,yy 67.9711.7*,y <0.001
Men, n (%) 16 (76.2%) 43 (89.6%) 22 (68.8%) 0.063
BMI, kg/m2 28.063.70 27.274.09 26.403.20 0.449
HT, n (%) 9 (42.9%) 13 (21.7%) 20 (62.5%) 0.007
DM, n (%) 3 (14.3%) 11 (22.9%) 9 (28.1%) 0.501P
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Objectıves: Red cell distribution width (RDW), a measure of the variability in size of
circulating erytrocytes, has been reported to be a risk marker of morbidity and
mortality for cardiovascular disease. In this study, we aimed to investigate the asso-
ciation of the NLR with Global Registry of Acute Coronary Events (GRACE) risk
score and in-hospital major advanced cardiac events in patients with STEMI under-
going primary percutaneous coronary intervention (PCI).
Materıal/Methods: We analyazed 101 consecutive STEMI patents treated with
primary PCI. Patients were divided into 3 groups by use of GRACE risk score. The
RDW was calculated as a part of automated complete blood count. The association
between RDW and GRACE risk score was assessed.
Results: Baseline Characteristics
The study population consisted of 101 consecutive STEMI patients. 80.2% of
patients were male and mean age of patients was 57.9712.24 years. 42 patients were
hypertensive,23 patients were diabetic,34 patients were hyperlipidemic and 57 were
smoker. According to the GRACE risk score,21 patients had low GRACE risk
scores,48 patients had intermediate GRACE risk scores, 32 patients had high GRACE
risk scores. Demographic and biochemical characteristics of patients in GRACE risk
score groups are shown in table 1. The RDW values were signiﬁcantly higher in
patients with intermediate and high GRACE risk scores than in the low GRACE risk
scores. There were no signiﬁcant differences between low and intermediate GRACE
risk scores in respect to RDW. (Table 1, Figure 1).
Correlation with In-Hospital Events During the in-hospital period, 11 patients
(10.9%) presented cardiac events (3 cardiac death, 2 reinfarction, 6 new-onset heart
failure). These patients had more advanced Killip functional class and higher GRACE
risk score. The occurrence of in hospital cardiac death, reinfarction or new-onset heart
failure was signiﬁcantly related to RDW at admission (15.111.56 vs. 13.641.18,
p¼0.002). Likewise RDW and GRACE risk score showed a signiﬁcant positive
correlation. (r¼0.376, p<0.001) (Figure 2). The cut off level of RDW which best
predicts an unfavorable in hospital cardiac events was 14.3 with a sensivity of 72.7%;
speciﬁty of 76% (Figure 3).
Conclusıons: RDW is a newly recognized and widely available diagnostic marker,
routinely performed hemogram. Unlike many other inﬂammatory markers and
bioassays, RDW is an inexpensive and readily available marker that provides an
additional level of risk scores in predicting inhospital and long-term outcomes.
Although the GRACE risk score is routinely used for stratiﬁcation of patients with
acute coronary syndrome, RDW may provide additional prognostic value. Increased
RDW is independently associated with a higher rate of in-hospital cardiac events. The
determination of RDW for risk stratiﬁcation of STEMI patients during hospitalization
may be useful.HPL, n (%) 11 (52.4%) 13(27.1%) 10 (31.3%) 0.116
Smoker, n (%) 15 (71.4%) 28 (58.3%) 14 (43.8%) 0.130
Glucose, (mg/dl) 162.864.0 151.452.1 192.2131.4 0.745
WBC, cells/ml 124593041 122693643 117874113 0.492
Hemoglobin (gr/dl) 13.842.06 14.11.62 14.291.45 0.637
Hematocrit (%) 41.15.1 41.74.3 42.03.9 0.764
RDW (%) 13.251.01z 13.561.25z,zz 14.521.29*,y <0.001
TroponinT, ng/dl 0.180.64z 0.631.86z,** 1.061.57*,y <0.001
Demographic and biochemical characteristics of patients in GRACE risk score groups
(Abbreviations: BMI, body mass index; HT, hypertension; DM, diabetes mellitus; HPL, hyper-
lipidemia; WBC, white blood cell; RDW, red cell distribution width y p<0.001 compared with
GRACE 108-140 points, z p<0.001 compared with GRACE>140 points, * p<0.001 compared
with GRACE<108 points, ** p¼0.007 compared with GRACE<108 points, yy p¼0.01
compared with GRACE<108 points, zzp¼0.407 compared with GRACE<108 points)
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